Trigeminal neuralgia is a condition characterized by episodes of intense facial pain that lasts from a few seconds to several minutes or hours. The pain occurs in areas of the face where the trigeminal nerve supplies normal sensation: cheek, jaw, teeth, gums and lips, and sometimes the eye or forehead. This condition causes sudden, sharp and very severe pain, usually only on one side of the face. The pain is described as feeling like stabbing electric shocks, burning, crushing, exploding or shooting pain.
Although tumors or blood vessels pressing on the nerve can cause trigeminal neuralgia, in some cases the cause is unknown. Patients describe areas on the face as being so sensitive that lightly touching the face or even air currents can trigger an episode of pain. However, in many patients, the pain is generated spontaneously without any apparent stimulation.
People with this condition may initially experience short, mild attacks, but trigeminal neuralgia can progress, causing longer, more frequent bouts of searing pain. If left untreated, the condition tends to worsen over time. It affects women more often than men, and is more likely to occur in people over age 50.
Treatments for Trigeminal Neuralgia
Because of the variety of treatment options available, doctors usually can effectively manage trigeminal neuralgia with medications, injections or surgery. Treatment usually starts with medication. However, over time, some patients eventually stop responding to medications, or may experience unpleasant side effects. For those people, injections or surgery provide other treatment options. Other treatment options for trigeminal neuralgia include alcohol injection, glycerol injection, balloon compression of the trigeminal nerve, radiofrequency thermal rhizotomy, and surgical rhizotomy.
Medications are used to lessen or block the pain signals sent to your brain, and are the most common initial treatment for trigeminal neuralgia. Some medications include anticonvulsants or antispasmodic agents.
Microvascular Decompression Surgery
Microvascular decompression is a delicate procedure that is performed through a small opening behind the ear. The goal of this procedure is to prevent a blood vessel from compressing the trigeminal nerve. The surgery is performed under general anesthesia.
Through this small opening, the neurosurgeon uses a powerful microscope to view the trigeminal nerve. From here, the surgeon meticulously separates the nerve from the artery that is pressing against it. To relieve the pressure, the surgeon inserts a Teflon® pad between the artery and the nerve, keeping the artery from touching the trigeminal nerve.
Illustration: Compression of Trigeminal nerve
Illustration: Pressure on Trigeminal nerve relieved
To make sure that other nerves are not damaged by the surgery, the surgeon carefully monitors nerve function of the facial and acoustic (hearing) nerves. This is done by gently inserting tiny electrodes (metal wires that conduct mild electrical signals) into the muscles around the eye and mouth.
After the Procedure
Following the decompression procedure, the neurosurgeon closes the bony opening behind the ear, and you will be awakened and allowed to recover from anesthesia. Once this pressure has been relieved, patients often report immediate and complete relief from the pain. Most people stay in the hospital for observation overnight. Pain relief is usually immediate and medications are gradually discontinued over a two- week period following surgery.
Another treatment option for trigeminal neuralgia is radiosurgery. Gamma Knife radiosurgery involves delivering a focused, high dose of radiation to the root of the trigeminal nerve. This treatment uses radiation to damage the trigeminal nerve and reduce or eliminate pain. Relief occurs gradually and can take several weeks to begin.
Swedish Cerebrovascular Center550 17th Avenue
Seattle, WA 98122
Map & Directions
Affiliated clinic: Cranial, Spine and Joint Clinic at Providence Everett
Patient Education: Brain Aneurysms
How you can help
Swedish is constantly working to ensure patients with debilitating neurological disorders have access to the best treatment options, the latest technology, and state-of-the-art facilities.